Breaking News

Alkermes Sells Gainesville GMP Facility to Recro

Streamlines manufacturing ops into Athlone and Wilmington facilities

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Alkermes plc has entered a definitive agreement to sell its manufacturing facility in Gainesville, GA, along with global rights and royalty revenue associated with Meloxicam IV/IM, to Recro Pharma for an initial cash payment of $50 million, development and commercialization milestones of as much as $120 million and royalties on sales of Meloxicam IV/IM. The transaction, subject to customary terms and conditions, is expected to close in 2Q15.   Assets inlcuded in the transaction are: the Gainesvi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters